MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2020
Historique:
received: 29 01 2020
accepted: 19 03 2020
entrez: 1 5 2020
pubmed: 1 5 2020
medline: 30 3 2021
Statut: epublish

Résumé

Macrophages are known to have an impact in cytokine signaling in the myriad of organs in which they reside and are classically known to be either pro-inflammatory (M1), anti-inflammatory (M2). Different classes of signaling molecules influence these states, of which, microRNAs represent key modulators. These are short RNA species approximately 21 to 23 nucleotides long that generally act by binding to the 3' untranslated region of mRNAs, regulating their translation, and, thus, the quantity of protein they encode. From these species, microRNA-155 was observed to be of great importance for M1 polarization. Because of it's major implication in M1 polarization microRNA-155 was shown to be implicated in different inflammatory diseases. To name a few, microRNA-155 was shown to be modified in patients with asthma and to correlate with asthma symptoms in mouse model; it has been shown to modulate the activity of foam cells and influence the dimensions of the atherosclerotic plaque and it has also been shown to be of crucial influence in transducing the signal of LPS in septic shock. Because of this, the current review aims to offer an overview of the role of microRNA-155 in M1 polarization, the implication that this poses for the pathophysiology of inflammatory diseases and the potential therapeutic possibilities that this knowledge might bring. Currently, microRNA-155 has been used in clinical trials as a marker of inflammation, but the question remains if it's inhibition will be useful in inflammatory diseases, as other products might have a better cost/benefit ratio.

Identifiants

pubmed: 32351507
doi: 10.3389/fimmu.2020.00625
pmc: PMC7174664
doi:

Substances chimiques

Cytokines 0
MIRN155 microRNA, human 0
MicroRNAs 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

625

Informations de copyright

Copyright © 2020 Pasca, Jurj, Petrushev, Tomuleasa and Matei.

Références

Nature. 2007 Jun 21;447(7147):972-8
pubmed: 17538624
Eur J Neurol. 2019 Jan;26(1):27-40
pubmed: 30300457
Science. 2000 May 26;288(5470):1439-41
pubmed: 10827957
Front Immunol. 2018 May 28;9:1175
pubmed: 29892301
Cells. 2019 May 08;8(5):
pubmed: 31071965
Int Arch Allergy Immunol. 2014;163(3):168-78
pubmed: 24513959
Free Radic Biol Med. 2012 Apr 15;52(8):1307-17
pubmed: 22326887
Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17475-80
pubmed: 19805133
J Allergy Clin Immunol. 2017 Jun;139(6):1946-1956
pubmed: 27746237
EMBO J. 2009 Nov 4;28(21):3341-52
pubmed: 19779457
Blood. 2010 Dec 23;116(26):5885-94
pubmed: 20852130
J Biol Chem. 2010 Dec 31;285(53):41328-36
pubmed: 21036908
Genes Dev. 1998 Aug 1;12(15):2403-12
pubmed: 9694804
Nat Commun. 2017 Oct 11;8(1):851
pubmed: 29021573
Nature. 2005 Sep 29;437(7059):759-63
pubmed: 16127449
Nat Rev Mol Cell Biol. 2019 Jan;20(1):5-20
pubmed: 30228348
Biomed Res Int. 2015;2015:326042
pubmed: 26697483
Exp Gerontol. 2019 Sep;124:110653
pubmed: 31295526
Nat Immunol. 2011 Mar;12(3):231-8
pubmed: 21240265
PLoS One. 2012;7(4):e35877
pubmed: 22558252
Nat Rev Immunol. 2011 Oct 25;11(11):750-61
pubmed: 22025054
Glia. 2011 Dec;59(12):1911-22
pubmed: 22170100
JAMA. 2018 Oct 2;320(13):1360-1372
pubmed: 30285183
Immunity. 2010 Nov 24;33(5):699-712
pubmed: 21093321
Nat Rev Immunol. 2008 Dec;8(12):958-69
pubmed: 19029990
Mediators Inflamm. 2016;2016:8060182
pubmed: 27843203
Gene. 2013 Dec 10;532(1):1-12
pubmed: 23246696
Sci Rep. 2017 Aug 8;7(1):7591
pubmed: 28790455
Nature. 2005 Mar 10;434(7030):243-9
pubmed: 15665823
Intern Emerg Med. 2018 Apr;13(3):325-331
pubmed: 29299831
Ann Neurol. 2013 Nov;74(5):709-20
pubmed: 23818336
Nature. 1998 Jan 1;391(6662):79-82
pubmed: 9422508
J Clin Invest. 2012 Nov;122(11):4190-202
pubmed: 23041630
J Immunol. 1997 Dec 1;159(11):5474-82
pubmed: 9548487
Am J Respir Cell Mol Biol. 2015 Apr;52(4):438-47
pubmed: 25180620
Arthritis Res Ther. 2008;10(4):R101
pubmed: 18759964
Front Endocrinol (Lausanne). 2018 Aug 03;9:402
pubmed: 30123182
Nature. 1996 Apr 18;380(6575):627-30
pubmed: 8602263
Exp Ther Med. 2017 Nov;14(5):4391-4396
pubmed: 29104649
Immunity. 1995 Dec;3(6):703-14
pubmed: 8777716
Cell Physiol Biochem. 2015;36(4):1371-81
pubmed: 26159489
Immunity. 2010 May 28;32(5):593-604
pubmed: 20510870
Science. 1994 Jun 3;264(5164):1415-21
pubmed: 8197455
Nat Immunol. 2010 Oct;11(10):936-44
pubmed: 20729857
Nat Rev Mol Cell Biol. 2019 Jan;20(1):21-37
pubmed: 30108335
Front Immunol. 2018 Jan 05;8:1932
pubmed: 29354135
Nat Rev Genet. 2008 Feb;9(2):102-14
pubmed: 18197166
Nat Rev Immunol. 2007 Feb;7(2):105-17
pubmed: 17259967
Mediators Inflamm. 2015;2015:121378
pubmed: 26696750
Oncogene. 2007 Oct 15;26(47):6816-28
pubmed: 17934488
Brain. 2009 Dec;132(Pt 12):3342-52
pubmed: 19952055
Blood. 2005 Jun 15;105(12):4685-92
pubmed: 15701712
J Biol Chem. 2014 Feb 14;289(7):4316-25
pubmed: 24362029
BMC Genomics. 2014 Aug 06;15:656
pubmed: 25099603
J Allergy Clin Immunol. 2013 Jul;132(1):217-9
pubmed: 23628339
J Immunol. 2018 Aug 1;201(3):916-929
pubmed: 29967100
Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1604-9
pubmed: 17242365
Annu Rev Cell Dev Biol. 2007;23:175-205
pubmed: 17506695
Nat Rev Dis Primers. 2019 Aug 16;5(1):56
pubmed: 31420554
Nat Rev Gastroenterol Hepatol. 2020 Jan;17(1):9-20
pubmed: 31767987
J Exp Med. 1993 Jan 1;177(1):225-30
pubmed: 8418203
J Immunol. 2007 Oct 15;179(8):5082-9
pubmed: 17911593
World J Gastroenterol. 2017 Feb 14;23(6):976-985
pubmed: 28246471
Rheumatology (Oxford). 2016 Nov;55(11):2056-2065
pubmed: 27411480
Arthritis Res Ther. 2010;12(3):R86
pubmed: 20470394
J Biol Chem. 2011 Jan 21;286(3):1786-94
pubmed: 21097505
Nat Immunol. 2008 Dec;9(12):1399-406
pubmed: 18978793
Nat Rev Immunol. 2005 Dec;5(12):953-64
pubmed: 16322748
Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):759-67
pubmed: 24504735
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7113-8
pubmed: 19359473
Immunity. 2000 Dec;13(6):795-804
pubmed: 11163195
J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S129-33
pubmed: 20586854
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6
pubmed: 16885212
Arthritis Rheum. 2008 Apr;58(4):1001-9
pubmed: 18383392
Mol Cell Biol. 2011 Oct;31(19):4087-96
pubmed: 21807897
Cell Mol Immunol. 2009 Oct;6(5):343-52
pubmed: 19887047
Scand J Immunol. 2017 Apr;85(4):300-307
pubmed: 28199728

Auteurs

Sergiu Pasca (S)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Ancuta Jurj (A)

Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Bobe Petrushev (B)

"Octavian Fodor" Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania.

Ciprian Tomuleasa (C)

Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
The Oncology Institute Prof. Dr. Ion Chiricuta, Cluj-Napoca, Romania.

Daniela Matei (D)

"Octavian Fodor" Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania.
Department of Gastroenterology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH